Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $9.7 in the last session, down -2.32% from day before closing price of $9.93. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 1.16 million shares were traded. CAPR stock price reached its highest trading level at $10.02 during the session, while it also had its lowest trading level at $9.47.
Ratios:
We take a closer look at CAPR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.55 and its Current Ratio is at 6.55. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Alliance Global Partners on June 30, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On June 26, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.
On May 20, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $31.Roth Capital initiated its Buy rating on May 20, 2025, with a $31 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Nippon Shinyaku Co Ltd bought 2,798,507 shares for $5.36 per share. The transaction valued at 14,999,998 led to the insider holds 7,090,351 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 452964768 and an Enterprise Value of 310350752. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.54 while its Price-to-Book (P/B) ratio in mrq is 3.47. Its current Enterprise Value per Revenue stands at 17.874 whereas that against EBITDA is -5.564.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.82, which has changed by 1.0082815 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $23.40, while it has fallen to a 52-week low of $3.52. The 50-Day Moving Average of the stock is -10.44%, while the 200-Day Moving Average is calculated to be -28.49%.
Shares Statistics:
According to the various share statistics, CAPR traded on average about 2.64M shares per day over the past 3-months and 4376390 shares per day over the past 10 days. A total of 45.68M shares are outstanding, with a floating share count of 40.15M. Insiders hold about 12.16% of the company’s shares, while institutions hold 40.22% stake in the company. Shares short for CAPR as of 1749772800 were 10214148 with a Short Ratio of 3.87, compared to 1747267200 on 13781994. Therefore, it implies a Short% of Shares Outstanding of 10214148 and a Short% of Float of 25.419999999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
